Columbus Venture Partners (VP)

Columbus Venture Partners (VP) is a venture capital firm based in Madrid, Spain, specializing in investing in biotechnology and pharmaceutical startups. Columbus VP has around €400 million in assets under management as of May 2024.

The firm specializes in the biotechnology and pharmaceutical sectors, targeting early-stage companies with strong scientific foundations. Columbus VP's investment strategy is characterized by a balanced focus on disruptive treatments and industrial development, with the objective of bringing groundbreaking therapies to market.

The Columbus VP team is led by its founders and managing partners, Javier García and Damià Tormo, along with partners Julen Oyarzábal, José Mesa, and Robert Armstrong. This leadership team brings extensive expertise in the life sciences sector, ensuring that investments are strategically guided toward success.

Columbus VP has a proven track record of impactful investments, having completed 27 investments and achieved a dozen successful exits with its previous funds. Notable exits include companies like Askbio, Viralgen, PTS, and Sanifit. The firm’s ability to support companies from early-stage development to successful exits has established it as a key player in the venture capital landscape within the biopharmaceutical industry.